The BRAF-inhibitor PLX4720 inhibits CXCL8 secretion in BRAFV600E mutated and normal thyroid cells: a further anti-cancer effect of BRAF-inhibitors

F. Coperchini, L. Croce, M. Denegri, O. Awwad, S.T. Ngnitejeu, M. Muzza, V. Capelli, F. Latrofa, L. Persani, L. Chiovato, M. Rotondi

Research output: Contribution to journalArticle

Original languageEnglish
JournalScientific Reports
Issue number1
Publication statusPublished - 2019

Cite this